Transparency Market Research (TMR) states that the leading players in the global pain management therapeutics market are Pfizer, Inc., Merck & Co, Inc., Johnson & Johnson, Endo Health Solutions, and Purdue Pharma LP. “The competition is projected to intensify in the coming years as several manufacturers are likely to be threatened by the entry of generic drug manufacturers,” stated the lead analyst Despite the cutthroat competition, Purdue Pharma LP and Pfizer, Inc. held a 50% share in the global market in 2015.
According to the research report, the global pain management therapeutics market is expected to be worth US$83.0 bn by the end of 2024 from US$60.2 bn in 2015. During the forecast period of 2016 and 2024, the global market is projected to surge at a CAGR of 3.7%. The slow-paced growth of the global market will be attributable to the high prevalence of chronic pain among various patients suffering from complicated medical problems
Cancer Pain Management Leads the Way for Global Market
The World Health Organization states that the rising cases of cancer across the world have provided the global market for pain management therapeutics lucrative opportunities. The disease comes with immense pain, which makes life miserable during the treatment as well as after the treatment. These therapeutics are also administered to those who are terminally ill patients who no longer have the strength to fight the pain. Owing to this reason alone, the cancer pain management segment held a share of about 28% in the global pain management therapeutics market in 2015 in terms of revenue.
Geographically, the global pain management therapeutics market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Of all the regions, North America dominated the global market as it held nearly half of the market in in 2015. The efficient healthcare sector of North America, rising expenditure on healthcare, and high level of awareness among patients are expected to fuel the progress of this regional market. Europe is expected to closely follow North America pain management therapeutics market as the region works toward offer better healthcare.
Investments to Develop Improved Molecular Combinations to Boost Market Growth
The growing pool of geriatrics, who are susceptible to a wide range of diseases that can be painful, have been the key consumers of pain management therapeutics in recent years. Arthritis, epilepsy, nerve damage, depression, cancer, diabetic neuropathy, and several other injuries that are seen among the aged are projected to drive the global market in the coming years. The global geriatric population is estimated to reach 2 billion by the end of 2050, raising the demand for pain management therapeutics by leaps and bounds.
The market is also being favored by the growing investments in research and development of new molecular combinations and improved methods of drug delivery. The supportive regulatory reforms that are in support of the drug development are also expected to set the global pain management therapeutic on the path of growth in the near future.
Patent Expiries Threaten Sales of High-earning Drugs
Despite the strong market drivers, the global pain management therapeutics market faces some tough challenges. The expected expiry of blockbuster pain management drugs is likely to hold back the sales for several big players in the market. The inroads by generic drugs will also restrain the sales of high-earning drugs by providing affordable alternatives to patients.
This review is based on Transparency Market Research’s review, titled “Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic; Indication - Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine, Post-operative Pain, Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
For this study, the market is segmented as follows:
Global Pain Management Therapeutics Market Revenue, by Therapeutics
- Non-steroidal Anti-inflammatory Drugs (NSAIDS)
- Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
- Antimigraine Agents
- Other Non-narcotic Analgesic
Global Pain Management Therapeutics Market Revenue, by Indication
- Neuropathic Pain
- Chronic Back Pain
- Arthritic Pain
- Post-operative Pain
- Cancer Pain
Global Pain Management Therapeutics Market, by Geography
- North America
- Asia Pacific (APAC)
- Rest of the World (RoW)
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453